- Home
- VSTM vs JUNS Comparison
VSTM vs JUNS Comparison
Compare VSTM & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- JUNS
- Stock Information
- Founded
- VSTM 2010
- JUNS 2015
- Country
- VSTM United States
- JUNS United States
- Employees
- VSTM N/A
- JUNS N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- JUNS
- Sector
- VSTM Health Care
- JUNS
- Exchange
- VSTM Nasdaq
- JUNS NYSE
- Market Cap
- VSTM 263.5M
- JUNS 281.4M
- IPO Year
- VSTM 2012
- JUNS 2024
- Fundamental
- Price
- VSTM $5.68
- JUNS $0.84
- Analyst Decision
- VSTM Strong Buy
- JUNS
- Analyst Count
- VSTM 8
- JUNS 0
- Target Price
- VSTM $12.67
- JUNS N/A
- AVG Volume (30 Days)
- VSTM 837.6K
- JUNS 602.5K
- Earning Date
- VSTM 03-13-2025
- JUNS 03-04-2025
- Dividend Yield
- VSTM N/A
- JUNS N/A
- EPS Growth
- VSTM N/A
- JUNS N/A
- EPS
- VSTM N/A
- JUNS N/A
- Revenue
- VSTM $10,000,000.00
- JUNS N/A
- Revenue This Year
- VSTM N/A
- JUNS N/A
- Revenue Next Year
- VSTM $117.91
- JUNS N/A
- P/E Ratio
- VSTM N/A
- JUNS N/A
- Revenue Growth
- VSTM N/A
- JUNS N/A
- 52 Week Low
- VSTM $2.10
- JUNS $0.78
- 52 Week High
- VSTM $13.82
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- VSTM 49.67
- JUNS N/A
- Support Level
- VSTM $5.48
- JUNS N/A
- Resistance Level
- VSTM $6.17
- JUNS N/A
- Average True Range (ATR)
- VSTM 0.32
- JUNS 0.00
- MACD
- VSTM -0.07
- JUNS 0.00
- Stochastic Oscillator
- VSTM 35.53
- JUNS 0.00
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.